The fair value of the Company’s accounts receivable, accounts payable, commercial paper and other short-term obligations approximate their carrying value based on existing terms.
Financial Instruments Measured at Fair Value on a Non-Recurring Basis
As of March 29, 2025 and December 28, 2024, the Company had non-marketable securities in privately-held companies of $
650
million and $
468
million, respectively, which are recorded at estimated fair value based on Level 3 inputs and within Other non-current assets in the Condensed Consolidated Balance Sheets.
Hedging Transactions and Derivative Financial Instruments
Foreign Currency Forward Contracts Designated as Accounting Hedges
The Company enters into foreign currency forward contracts to hedge its exposure to foreign currency exchange rate risk related to future forecasted transactions denominated in currencies other than the U.S. Dollar. These contracts generally mature within
24
months and are designated as accounting hedges. As of March 29, 2025 and December 28, 2024, the notional value of the Company’s outstanding foreign currency forward contracts designated as cash flow hedges was $
2.1
billion and $
2.2
billion, respectively. The fair value of these contracts as of March 29, 2025 is recorded within Prepaid expenses and other current assets, Accrued liabilities, and Other long-term liabilities of $
7
million, $
37
million and $
4
million, respectively. The fair value of these contracts as of December 28, 2024 is recorded within Prepaid expenses and other current assets, Accrued liabilities, and Other long-term liabilities of $
6
million, $
60
million and $
11
million, respectively.
Foreign Currency Forward Contracts Not Designated as Accounting Hedges
The Company also enters into foreign currency forward contracts to reduce the short-term effects of foreign currency fluctuations on certain receivables or payables denominated in currencies other than the U.S. Dollar. These forward contracts generally mature within
3
months and are not designated as accounting hedges. As of March 29, 2025 and December 28, 2024, the notional value of these outstanding contracts was $
868
million and $
642
million, respectively. The fair value of these contracts was not material as of March 29, 2025 and December 28, 2024.
17
Table of Contents
NOTE 9 –
Earnings Per Share
The following table sets forth the components of basic and diluted earnings per share:
Securities which would have been anti-dilutive are not material and are excluded from the computation of diluted earnings per share for all periods presented.
NOTE 10 –
Common Stock and Stock-based Compensation
Common Stock
Shares of common stock outstanding were as follows:
Stock Repurchase Program
The Company has an approved stock repurchase program authorizing repurchases of up to $
12
billion of the Company’s common stock (Repurchase Program). During the three months ended March 29, 2025, the Company repurchased
7
million shares of its common stock under